Introduction {#s1}
============

Advanced maternal age (AMA), generally referred to as childbearing in women aged 35 years or older, is an increasing worldwide phenomenon ([@DEW177C30]; [@DEW177C16]; [@DEW177C47]). It is generally accepted that as maternal age increases there is a decline in the population of primordial follicles in the ovaries ([@DEW177C44]) and an increase in the presence of chromosomal abnormalities in oocytes ([@DEW177C22]) with consequences for fertility. Indeed, epidemiological studies in humans have revealed that AMA is associated with reduced capacity to conceive ([@DEW177C14]) and increased risk of miscarriage ([@DEW177C24]). Adverse pregnancy outcomes have also been reported, and although the evidence is not entirely consistent, a wealth of data from human studies supports the notion that AMA is a risk factor for congenital abnormalities ([@DEW177C11]), stillbirth ([@DEW177C30]), preterm birth ([@DEW177C23]), perinatal death ([@DEW177C30]), macrosomia ([@DEW177C23]), large for gestational age ([@DEW177C23]), small for gestational age ([@DEW177C24]), low birthweight ([@DEW177C16]) and Caesarean delivery ([@DEW177C24]).

Although inconsistencies among studies exist, epidemiological studies have also shown that AMA can affect human offspring during post-natal life. For instance, there is evidence supporting an increased risk of behavioural alterations in children of women of AMA, including autism spectrum disorders ([@DEW177C32]). The risk of developing diabetes has been examined in a meta-analysis of 30 studies which revealed that children born to women of AMA have an increased risk of type 1 diabetes ([@DEW177C8]). In young adults with mothers of AMA, this latter association was not observed, but AMA was linked with the risk of early onset type 2 diabetes ([@DEW177C29]). A recent study reported that young adults with mothers of AMA displayed increased fasting plasma glucose concentrations ([@DEW177C16]). Cardiovascular function can also be affected, as shown by the positive association observed between maternal age at conception and blood pressure in children aged 5--7 years ([@DEW177C63]; [@DEW177C31]), and the high blood pressure found in newborns of mothers of AMA ([@DEW177C19]). There are also indications that AMA may decrease the lifespan ([@DEW177C64]) and reproductive capacity of human offspring ([@DEW177C54]; [@DEW177C51]).

In contrast, positive effects attributed to AMA have been reported in human studies. For example, several studies indicate that AMA seems to exert a positive effect on some behavioural and cognitive outcomes in children ([@DEW177C57]). A UK-based study found that children of mothers of AMA had a decreased risk of unintentional injuries and admissions to hospital, better language development, increased likelihood of having a complete immunization schedule by age 9 months, and improved ability to deal with social and emotional difficulties ([@DEW177C53]). Children of women of AMA were also taller, slimmer and displayed decreased abdominal adiposity and plasma concentrations of insulin-like growth factor-2 ([@DEW177C48]). Moreover, a study conducted in 73 overweight middle-age males reported that as the age of their mothers at childbearing increased (range 18--45 years), the better the metabolic and cardiovascular phenotype they showed, including improved insulin sensitivity, decreased fasting concentrations of insulin and glucose, and lower blood pressure ([@DEW177C2]). Similarly, another recent study found an inverse relationship between maternal age at childbearing and fasting glucose levels in young adult offspring ([@DEW177C58]). However, it has been suggested that these positive effects of AMA are probably caused by environmental factors and may not be directly related to biological mechanisms of reproductive aging. In this context, in some populations, older mothers will have better socioeconomic status and/or greater knowledge about healthy lifestyles (e.g. breastfeeding, balanced nutrition, physical activity, etc.), which, in turn, will give an advantage for the implementation of a healthier and safer environment for child-rearing with long-term positive consequences in adulthood ([@DEW177C64]; [@DEW177C2]; [@DEW177C57]). Some authors believe that environmental factors may also be the cause for some of the adverse effects attributed to AMA in human studies, as the negative effect of AMA on offspring longevity and body weight (i.e. obesity) lost significance after controlling for factors such as maternal education, socioeconomic status and early parental loss ([@DEW177C40]; [@DEW177C41]).

Besides the difficulty in controlling confounding factors, human retrospective studies cannot delineate the long-term effects of AMA from those attributed to delayed fatherhood ([@DEW177C40]; [@DEW177C2]). This highlights the importance of experimental animal models. Experimental work in mice indicated that AMA can affect post-natal development of offspring derived from natural reproduction. Accordingly, AMA was associated with higher pup mortality in the first 3 days after birth ([@DEW177C55]), lower body weight during the preweaning period ([@DEW177C55]), behavioural alterations at post-natal Weeks 8--10 ([@DEW177C33]) or 24--37 ([@DEW177C55]), lower body weight during post-natal Weeks 40--90, and decreased lifespan ([@DEW177C56]). However, there is a lack of information on the long-term effects of AMA on metabolic and cardiovascular function of offspring in experimental animal models. Furthermore, given the increasing trend in the use of assisted reproduction technology (ART) to alleviate infertility in women of AMA ([@DEW177C5]; [@DEW177C21]), it is imperative to develop experimental ART models of AMA. These studies will discriminate between AMA effects on the preimplantation embryo itself from those that may derive from the maternal tract and systemic environment of the pregnancy following embryo transfer (ET).

In the present study, using a murine ET model, we examine the effects of AMA on the post-natal development of offspring under an ART-derived procedure. To avoid potential adverse programming from ovulation induction, IVF and extended embryo culture, and paternal conditions ([@DEW177C60]; [@DEW177C15]) and to focus attention on outcomes mainly related to maternal age of embryos, we used aged or young females naturally mated to young males, with subsequent collection and immediate transfer of blastocysts to young recipients. We provide evidence that offspring of aged mice display alterations in body weight gain, blood pressure, glucose metabolism and organ allometry during post-natal development that predominantly affect females. Furthermore, our data demonstrate that these adverse phenotypes are already programmed by the blastocyst stage.

Materials and Methods {#s2}
=====================

Animals {#s2a}
-------

All animal experimentation was conducted in accordance with the UK Home Office Animal (Scientific Procedures) Act 1986 and local ethics committee at the University of Southampton. All animals were bred in-house (University of Southampton, Biomedical Research Facility) and kept on a 0700--1900 h light cycle at a temperature of 20--22°C. Water and standard laboratory chow (Special Diet Services, Ltd, Witham, Essex, UK) was provided *ad libitum* to all animals used in the study.

*In vivo* production of blastocysts {#s2b}
-----------------------------------

Non-superovulated virgin young (8--9 weeks) and old (34--39 weeks) female mice (C57BL/6) were mated with young CBA males (10--15 weeks; Fig. [1](#DEW177F1){ref-type="fig"}). Male--female pairs were housed overnight and the presence of a vaginal plug the following morning was regarded as a sign of successful mating. Females were considered to be on embryonic Day 0.5 (E0.5) at midday on the day the vaginal plug was detected. On E3.5 mice were killed by cervical dislocation and uterine horns were immediately dissected and placed in warm (37°C) saline solution (BR0053G, OXOID, UK). Each uterine horn was then gently flushed on an empty petri dish, under a stereomicroscope, with 1 ml of H6 medium supplemented with 4 mg/ml bovine serum albumin (BSA, A3311, Sigma, UK; [@DEW177C42]). Arrested and/or fragmented embryos at the 2- to 8-cell stage were classified as degenerated embryos. Morula and blastocyst with clear signs of fragmentation were also considered degenerated embryos. All non-fragmented 1-cell structures (i.e. absence of first cleavage division) were classified as unfertilized oocytes (i.e. ova; [@DEW177C66]). All embryos in the stage of morula or blastocyst with no signs of fragmentation were classified as viable embryos. Viability (total viable embryos/total embryos × 100), fertilization (total embryos/total embryos + ova × 100) and degeneration (degenerated embryos/total embryos × 100) rates were calculated. Blastocysts were washed three times in H6-BSA medium to remove debris. Collected blastocyst were either subjected to differential cell staining or transferred to 30 µl drops (10--15 blastocysts per drop) of synthetic oviductal medium enriched with potassium medium ([@DEW177C52]) and incubated under 5% CO~2~ in air at 37°C for 2--3 h until the time of ET. Figure 1Murine model of AMA used in the study. Young (8--9 weeks) or old (34--39 weeks) C57BL/6 females were mated with young CBA males (10--15 weeks) to obtain young or old blastocysts (Day 3.5 of pregnancy). Blastocysts were then transferred to young MF1 recipients (8--9 weeks) to obtain young (Young-ET) or old (Old-ET) embryo-derived offspring. ET, embryo transfer.

Differential cell staining in blastocysts {#s2c}
-----------------------------------------

Blastocysts with a blastocoel cavity greater than half of the volume of the embryo (i.e. expanded blastocysts) were subjected to differential nuclear labelling according to the protocol developed by [@DEW177C20] with some modifications. Unless otherwise indicated, embryos were processed in 50 µl drops. After removing the zona pellucida in 1 ml of warm (37°C) acid Tyrode\'s solution (T1788, Sigma), blastocysts were washed for 15--20 min in 1 ml H6-BSA followed by 10 min incubation in 10% trinitrobenzenesulfonic acid solution (TNBS, P-2297, Sigma) at room temperature. H6 medium supplemented with 1% polyvinylpyrrolidone (PVP, P0930, Sigma) was used to prepare the 10% TNBS solution. Blastocysts were then washed three times in H6-PVP and incubated for 10 min in 0.4 mg/ml goat anti-dinitrophenyl antibody (D9781, Sigma) in H6-PVP at room temperature. After washing three times in H6-PVP, blastocysts were incubated in 50 µl of reconstituted (1:10 dilution with H6-BSA) Low-Tox^®^ guinea pig complement (CL4051, Cedarlane, Canada) supplemented with 4 µl propidium iodide (1 mg/ml, P4170, Sigma) for 15 min at 37°C. Blastocysts were washed again three times with H6-BSA and fixed in 1 ml ice-cold ethanol supplemented with 1% Bisbenzimide H 33258 (2.5 mg/ml, B2883, Sigma) at 4°C for 1 h. For cell quantification, blastocysts were washed in 1 ml ice-cold fresh ethanol and mounted onto a glass microscope slide in a ∼4 µl drop of glycerol (G5516, Sigma) and coverslipped. Digital photographs of blastocysts were obtained with an inverted epifluorescence microscope (Axiovert 200M, Carl Zeiss Ltd) in a darkened room. Cell nuclei were manually counted with the MetaMorph software (Version 6.2r6, Molecular Devices).

Embryo transfer {#s2d}
---------------

Blastocysts were washed three times in M2 medium before ET ([@DEW177C60]). The uterine horn was exposed by flank laparotomy and six expanding blastocysts were transferred with a minimal amount of medium into the uterine cavity of MF1 pseudo-pregnant (E2.5) young recipients (8--9 weeks; Fig. [1](#DEW177F1){ref-type="fig"}). The uterine horn was then placed back into the abdominal cavity and the incision site closed. The procedure was repeated in the opposite flank where another six expanding blastocysts were transferred. Following ET, recipients were placed individually in clean cages to recover from anaesthesia in a warm room (28--30°C). Females were then moved to a quiet room where they were kept for the rest of the pregnancy and lactation.

Offspring analysis {#s2e}
------------------

ET-derived offspring were weaned 3 weeks after birth, separated according to sex, and their body weight recorded weekly for 30 weeks. Systolic blood pressure was measured with a standard protocol at post-natal Weeks 9, 15 and 21 by tail-cuff plethysmography with the Non-Invasive Blood Pressure Monitor (NIBP-8, Columbus Instruments, Columbus, OH, USA) in a warm room (28--30°C; [@DEW177C60], [@DEW177C61]). Five readings with good waveforms and good overall quality were obtained per mouse ([@DEW177C65]). At post-natal Week 30 a standard protocol for glucose tolerance test (GTT) was performed in unrestrained conscious mice following a 15 h overnight fast. A blood glucose metre (Accu-Chek, Aviva, Roche Diagnostics GmbH, Germany) was used to measure glucose in small drops of blood collected by tail tipping. Twenty minutes before starting the GTT, anaesthetic cream (Lidocaine 5%, Teva, UK) was applied to the tail. After recording of the baseline glucose level (0 min), a glucose (G8270, Sigma) solution (20%, in sterile, distilled water) was administered by i.p. injection at a dose of 2 g/kg. Glucose levels were measured 15, 30, 60 and 120 min after glucose administration ([@DEW177C9]; [@DEW177C62]). Water was provided *ad libitum* during fasting and GTT. Immediately after the GTT, mice were placed in clean cages with food and water *ad libitum*. Two days after the GTT, mice were killed by cervical dislocation and organs (i.e. spleen, liver, left and right kidneys, heart and lungs) and carcass weighed.

Statistics {#s2f}
----------

Statistical analysis was performed with the IBM SPSS Statistics Software, Version 21 (IBM Corporation UK Ltd, Hampshire, England). All data were tested for normal distribution with the Shapiro--Wilk test. Fertility and blastocyst cell allocation variables were analysed by *T*-test or *χ*^2^ as appropriate. Percentage data analysed with *T*-test were arcsine transformed before analysis. Litter size and sex allocation of pups following ET was analysed with *T*-test and binomial test, respectively. The rest of the post-natal data were analysed with a multilevel random effects regression model taking into consideration the random effects of mother and litter size. Post-natal data subjected to regression analysis were not normally distributed and Fisher--Yates transformations were carried out on the outcome variables before analysis ([@DEW177C10]). Of the five blood pressure readings taken at each time point per mouse, the lowest and highest values were discarded and the mean of the three middle values was used for statistical analysis ([@DEW177C65]). Area under the curve values were calculated for GTT data by the trapezoidal rule ([@DEW177C38]). Data are presented as mean ± SEM unless otherwise indicated.

Results {#s3}
=======

Maternal aging can alter cell allocation of blastocysts in mice {#s3a}
---------------------------------------------------------------

The percentage of plug-positive females that failed to yield embryos (Fig. [2](#DEW177F2){ref-type="fig"}A) and the number of embryos produced per donor was not different between the age groups (Fig. [2](#DEW177F2){ref-type="fig"}C). However, the fertilization rate was decreased in aged females (Fig. [2](#DEW177F2){ref-type="fig"}B). Some of the embryos were subjected to differential cell staining and the analysis revealed a decrease in the total number of cells in blastocysts of aged mice due to a lower number of cells in the trophectoderm (Fig. [3](#DEW177F3){ref-type="fig"}A). Other variables of cell allocation were not affected (Fig. [3](#DEW177F3){ref-type="fig"}B). Figure 2Effects of AMA on fertility outcome in mice. (**A**) Percentage of non-superovulated mice with a vaginal plug that failed to yield embryos (*n* = females mated; χ^2^). Larger numbers of replicates were generated for the old treatment group reflecting additional samples required for future studies and researcher training. (**B** and **C**) Embryo production variables (*n* = females mated that yielded embryos; *T*-test). Arrested and/or fragmented embryos at the 2- to 8-cell stage along with morula and blastocyst with clear signs of fragmentation were classified as degenerated embryos. All non-fragmented 1-cell structures were classified as unfertilized oocytes (i.e. ova). All embryos in the stage of morula or blastocyst with no signs of fragmentation were classified as viable embryos. \*Indicates a significant difference (*P* \< 0.05) between the embryo donors (Young versus Old). Figure 3Effects of AMA on cell number of blastocysts in mice. Blastocyst stained had a blastocoel cavity greater than half of the volume of the embryo (i.e. expanded blastocysts). (**A**) Cell number in trophectoderm (TE) and inner cell mass (ICM; *n* = embryos analysed from 6 Young and 18 Old mothers; *T*-test). (**B**) Cell allocation variables. \*Indicates a significant difference (*P* \< 0.05) between the embryo donors (Young versus Old).

Offspring derived from blastocysts collected from aged mice show an increased weight gain during post-natal life in a sex-specific manner {#s3b}
-----------------------------------------------------------------------------------------------------------------------------------------

To examine the effects of AMA on the post-natal development of offspring under an ART-derived procedure, we transferred blastocysts from old mothers into young surrogates and the resultant offspring (Old-ET) was compared with offspring derived from blastocysts collected from young mothers that were transferred into equivalent young surrogates (Young-ET; Fig. [1](#DEW177F1){ref-type="fig"}). Following ET, the number of pups per litter was not different between the groups (Fig. [4](#DEW177F4){ref-type="fig"}A), nor the efficiency of ET to yield live offspring (Old 66%; Young 65%). Similarly, the male to female proportion was not affected by origin of the embryo (Fig. [4](#DEW177F4){ref-type="fig"}B). Monitoring of body weight every week revealed no differences in weight gain in male offspring across treatments at any time point during the experimental trial (Fig. [5](#DEW177F5){ref-type="fig"}A). In contrast, Old-ET females were heavier than Young-ET females during most of post-natal development. The difference in body weight started to become apparent at post-natal Week 13 and remained significant for virtually the rest of the study (Fig. [5](#DEW177F5){ref-type="fig"}C). Figure 4Effects of AMA on ET outcome in mice. (**A**) Number of pups per litter following ET (*n* = litters analysed; *T*-test). (**B**) Sex allocation of pups following ET (*n* = total offspring number; Binomial test). Offspring is the result of the transfer of blastocysts collected from young (Young-ET) or old (Old-ET) embryo donors into young embryo recipients. Figure 5AMA can affect growth and cardiovascular function in mice. Post-natal body weight and blood pressure in male (**A** and **B**) and female (**C** and **D**) offspring derived from the transfer of blastocysts collected from young (Young-ET, 9 litters) or old (Old-ET, 10 litters) mothers into young embryo recipients. *n* = number of animals. Multilevel random effects regression analysis. \*Indicates a significant difference (*P* \< 0.05) between the groups (Young-ET versus Old-ET).

Offspring derived from blastocysts collected from aged mice develop hypertension during post-natal life in a non-sex-specific manner {#s3c}
------------------------------------------------------------------------------------------------------------------------------------

Non-invasive systolic blood pressure measurements were carried out in the offspring at post-natal Week 9, 15 and 21. The analysis showed a significant increase in blood pressure in Old-ET male offspring at Weeks 9 and 15 compared with Young-ET counterparts (Fig. [5](#DEW177F5){ref-type="fig"}B). However, by Week 21 systolic blood pressure values were not significantly different between the groups (Fig. [5](#DEW177F5){ref-type="fig"}B). A similar scenario was observed in female offspring, but the difference was only significant at post-natal Week 15 (Fig. [5](#DEW177F5){ref-type="fig"}D). The average of the three measurements was higher in Old-ET offspring for both sexes (Males: 106.6 ± 1.4 versus 102.6 ± 0.9 mmHg; Females: 105.0 ± 1.4 versus 101.5 ± 0.7 mmHg), but it did not reach statistical significance (*P* \< 0.10).

Offspring derived from blastocysts collected from aged mice display altered glucose homeostasis in a sex-specific manner {#s3d}
------------------------------------------------------------------------------------------------------------------------

Offspring were subjected to an i.p. GTT at the end of the study on post-natal Week 30. Basal glucose concentrations following overnight fasting (i.e. 0 min) were not different between the groups in both sexes (Fig. [6](#DEW177F6){ref-type="fig"}A and B). In male offspring, glucose levels at different time points after glucose administration and the area under the curve were not affected by the origin of the offspring (Fig. [6](#DEW177F6){ref-type="fig"}A). In contrast, Old-ET females showed a greater peak glucose concentration 30 min after glucose injection compared with Young-ET counterparts (Fig. [6](#DEW177F6){ref-type="fig"}B). However, 60 min after glucose administration the difference started to lose significance (*P* = 0.050), and by 120 min post glucose injection glucose levels have returned to basal values and were very similar between the groups. The area under the curve in Old-ET females (Fig. [6](#DEW177F6){ref-type="fig"}B) was higher compared with Young-ET counterparts, but the difference was not significant (*P* \< 0.10). Figure 6AMA can affect glucose metabolism in mice. Intraperitoneal GTT outcome in male (**A**) and female (**B**) offspring derived from the transfer of blastocysts collected from young (Young-ET, 9 litters) or old (Old-ET, 10 litters) mothers into young embryo recipients. *n* = number of animals. Multilevel random effects regression analysis. \*Indicates a significant difference (*P* \< 0.05) between the groups (Young-ET versus Old-ET).

Offspring derived from blastocysts collected from aged mice exhibit altered organ allometry in a sex-specific manner {#s3e}
--------------------------------------------------------------------------------------------------------------------

Analysis of organ allometry was carried out at the end of the study on post-natal Week 30. No significant differences in carcass weight were observed in males (38.5 ± 0.5 and 40.0 ± 1.0 g for Old-ET and Young-ET offspring, respectively). In contrast, the carcass weight of females was higher in the Old-ET group (32.9 ± 0.6 versus 29.3 ± 0.7 g, *P* \< 0.05). In male offspring, organ weights and organ weight:body weight ratios were not different between the groups (Fig. [7](#DEW177F7){ref-type="fig"}A and B). However, in Old-ET females the spleen was lighter compared with Young-ET females (Fig. [7](#DEW177F7){ref-type="fig"}C). Furthermore, the organ weight:body weight ratio for heart, lungs, spleen and liver were decreased in Old-ET females (Fig. [7](#DEW177F7){ref-type="fig"}D). Most of the internal organs of female offspring were of similar weight between the groups. Hence, with the exception of the spleen, the undersized organs in Old-ET females are more related to their increased body weight. Figure 7AMA can affect organ size in mice. Organ allometry variables in male (**A** and **B**) and female (**C** and **D**) offspring derived from the transfer of blastocysts collected from young (Young-ET, 9 litters) or old (Old-ET, 10 litters) mothers into young embryo recipients. *n* = number of animals. Multilevel random effects regression analysis. \*Indicates a significant difference (*P* \< 0.05) between the groups (Young-ET versus Old-ET).

Discussion {#s4}
==========

In this study, we have investigated the long-term effects of AMA on offspring development during post-natal life. Using an ET model our data show that offspring derived from embryos collected from aged female mice (mated with young males) and transferred into young embryo recipients display alterations in body weight gain, blood pressure, glucose metabolism and organ allometry during post-natal development. Most of the altered phenotypes were observed in a sex-specific manner, where females were more affected. Our study is the first to examine metabolic and cardiovascular function in offspring of aged female mice under an ART-related procedure. The fact that phenotypic alterations were observed under a normalized maternal *in vivo* environment following ET indicates that some of the adverse programming induced by AMA is already established by the time the embryo reaches the blastocyst stage and independent of subsequent conditions of pregnancy. In support of our current findings, experimental evidence in rodents and ruminants has shown that altered phenotypes during post-natal life can be programmed during the periconceptional period when critical reproductive events such as ovarian folliculogenesis and/or preimplantation embryo development are exposed to undernutrition ([@DEW177C50]; [@DEW177C61]), overnutrition ([@DEW177C45]; [@DEW177C25]), ART-related procedures ([@DEW177C60]; [@DEW177C46]; [@DEW177C13]; [@DEW177C35]) or inflammation-like events ([@DEW177C65]).

We used 34--39-week-old mice in our AMA model in an effort to reflect the onset of reproductive aging in middle-aged females rather than substantial loss of reproductive function during advanced senescence. Indeed, in our study the number of embryos recovered from non-superovulated old mice was not affected, which is comparable with the lack of effect of AMA on litter size following natural mating reported in AMA studies with mice of similar ages ([@DEW177C34]; [@DEW177C67]). Although cases of pregnancies in women in their 60s have been reported ([@DEW177C12]), we believe our model is more akin with the current trend in delayed childbearing, in which middle-aged women rather than elderly individuals are more likely to delay motherhood. Human embryos from aging mothers are known to show an increase in aneuploidy, contributing to reduced fertility with age ([@DEW177C39]; [@DEW177C22]). In comparison, depending on the mouse strain ([@DEW177C68]), murine embryos are less likely to display aneuploidy ([@DEW177C7]), especially in the age range used in the present study ([@DEW177C22]). This distinction, although reflecting a difference to the conditions normally encountered during human assisted conception practice, is to our advantage in the current mouse model since it permits increased survival to screen post-natal health in relation to maternal age. Indeed, it is believed that aneuploidy is the main cause of human IVF failure, resulting in implantation failure, miscarriage or birth of offspring with congenital disorders ([@DEW177C6]; [@DEW177C17]). Moreover, from a clinical practice perspective, our model relates to conditions of human gestational surrogacy where AMA embryos are transferred to a younger recipient and the potential programming of such embryos mediated through donor maternal age.

Our results indicate that maternal aging can induce a decrease in the number of cells at the blastocyst stage, especially in the trophectoderm. A recent study in rats reported that growth-restricted females with AMA at conception produced blastocysts with decreased cell number attributed to a lower cell number in trophectoderm ([@DEW177C37]). Low cell number in blastocysts has been associated with decreased placental and fetal weight in a mouse model of mitochondrial dysfunction ([@DEW177C59]). We did not analyse fetal development in our study, but a reduction in embryo size and somite number without alterations in litter size has been reported in a murine model of AMA ([@DEW177C34]). In our study, birthweight was not examined, but our data suggest that deviation in cell proliferation at early stages of development is an early sign of impaired post-natal health. Indeed, rodent offspring developing high blood pressure in adulthood showed alterations in cell number at the blastocyst stage after exposure to undernutrition or to an *in vitro* environment during the preimplantation period ([@DEW177C27]; [@DEW177C60]).

The subtle impairment of glucose homeostasis found in female offspring of old mice in our study gives partial support to a recent multi-country study that suggested that AMA can induce increased plasma glucose concentrations in young adults ([@DEW177C16]). However, in that epidemiological human study the impaired glucose metabolism was not sex-specific ([@DEW177C16]), which contrast with our results. It will be interesting to test under experimental conditions if this lack of gender specificity on post-natal glucose metabolism is due to an added effect of paternal aging. Previous epidemiological human studies also failed to detect an effect of AMA on offspring body weight ([@DEW177C40]) or blood pressure ([@DEW177C16]; [@DEW177C58]) during adulthood. Here, it is important to highlight that in epidemiological studies it is extremely difficult to control relevant confounding factors and to collect accurate long-term information on lifestyle habits and health status. Under well-controlled experimental conditions in mice, we found that maternal aging can programme the development of high blood pressure in adulthood in a non-sex-specific manner. However, the high blood pressure observed in Old-ET offspring was accompanied by increased body weight only in females. Similarly, in previous experiments examining the effects of undernutrition ([@DEW177C61]) and *in vitro* culture ([@DEW177C60]) during the periconceptional period in mice, we found increases in blood pressure in male offspring without noticeable changes in body weight during post-natal development. The lack of association between cardiac activity and body conformation has also been observed in another model of developmental programming in which male offspring of obese mice showed alterations during post-natal development in several variables associated with cardiovascular function independently of body weight ([@DEW177C4]).

It is believed that sex chromosome dosage differences between males and females are behind the gender-specific offspring phenotypes found on programming trajectories ([@DEW177C28]). In this scenario, gene dosage differences on sex chromosomes would affect differently the transcriptional activity of autosomal genes, resulting in sex-biased modulatory interactions in gene networks that would affect a large fraction of the genome, the 'sexome', which in turn will produce sex-specific phenotypes ([@DEW177C3]). Sex-specific differences in gene expression, mitochondrial function and epigenetic function are present at the preimplantation stage that could be expected to last beyond embryogenesis ([@DEW177C28]).

Interestingly, our AMA model showed several similarities with our previous study examining the long-term effects of extended *in vitro* embryo culture in mice ([@DEW177C60]). In that study, a low cell number in both the trophectoderm and the inner cell mass was associated with increased body weight exclusively in females and high blood pressure in offspring regardless of sex ([@DEW177C60]). However, even brief embryo culture (2 h) before blastocyst transfer was sufficient to minimally increase offspring blood pressure ([@DEW177C60]). Hence, a combined effect of maternal aging of embryos and their *in vitro* culture and transfer most probably are behind the altered post-natal phenotype observed in the present study. Nevertheless, our aim was to develop a model that reflects to a certain extent the current use of ART in women of AMA ([@DEW177C5]; [@DEW177C21]). The use of ET in our study most probably accounts for the increase in body weight, which contrasts with previous reports of lower post-natal body weight in offspring of normally mated aged mice, coupled with the aged maternal tract environment ([@DEW177C56]). However, notably, in both models the deviation in body weight after weaning was observed, not early, but later during post-natal development. Moreover, the decreased spleen weight associated with AMA we observed in our study was also found in mice offspring derived from natural pregnancies of old mothers ([@DEW177C1]). It is unknown at present if this decreased spleen weight will impact the functioning of the immune system.

Mitochondrial dysfunction associated with increased oxidative stress in oocytes has been suggested as a possible mechanism behind the long-term effects of aging ([@DEW177C55]). Indeed, several studies in mice and humans have found altered mitochondrial function in oocytes from aged females ([@DEW177C26]). Epigenetic modification has been also suggested as a potential mechanism underlying the periconceptional programming of disease occurrence in adulthood ([@DEW177C36]) and several epigenetic modifications in oocytes from aged mice and humans have been documented ([@DEW177C18]). However, a direct association between these oocyte alterations and long-term programming of disease has not been reported. In addition, although experimental evidence has indicated that uterine aging is accompanied by molecular and morphological changes that can be detrimental for fertility ([@DEW177C44]), the contribution of the microenvironment in the oviduct and uterus of aged mothers to long-term programming of phenotypes during post-natal life is largely unknown. Interestingly, a recent study with reciprocal ovarian transplants between young and old mothers indicated that the uterine environment, but not the oocyte, plays a crucial role in the development of congenital heart defects in offspring of old mice ([@DEW177C49]).

Given that the impaired oocyte quality and the development of congenital heart disease attributed to AMA can be ameliorated with nutritional or exercise interventions ([@DEW177C43]; [@DEW177C49]), it is critical to determine if the risk of developing altered post-natal phenotypes associated with AMA can be decreased with similar interventions. We recognize that data from animal models cannot be extrapolated to humans, but they are valuable to develop conceptual models that can produce verifiable hypotheses for eventual testing in the target species (i.e. humans).

In conclusion, in a murine ART--AMA model, we have shown that maternal aging can programme the development of impaired metabolic and cardiovascular function during post-natal life. Furthermore, our data also indicate that the preimplantation period is a developmental window in which adverse programming can be exerted by AMA and be independent of the maternal tract and systemic environment where pregnancy subsequently occurs. Hence, whilst human embryos display increased aneuploidy compared with mouse, we believe our data have implications for women of AMA undergoing assisted reproduction, including surrogacy programmes.
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